Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening

RA Smith, D Manassaram‐Baptiste… - CA: a cancer journal …, 2015 - Wiley Online Library
Answer questions and earn CME/CNE Each year, the American Cancer Society (ACS)
publishes a summary of its guidelines for early cancer detection along with a report on data …

The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA

K Fleshner, SV Carlsson, MJ Roobol - Nature Reviews Urology, 2017 - nature.com
Guidelines regarding recommendations for PSA screening for early detection of prostate
cancer are conflicting. In 2012, the United States Preventive Services Task Force (USPSTF) …

Cancer statistics, 2015.

RL Siegel, KD Miller, A Jemal - CA: a cancer journal for …, 2015 - search.ebscohost.com
Abstract Each year the American Cancer Society estimates the numbers of new cancer
cases and deaths that will occur in the United States in the current year and compiles the …

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

KAO Tikkinen, P Dahm, L Lytvyn, AF Heen… - Bmj, 2018 - bmj.com
There is considerable variability among men's values and preferences regarding prostate
cancer screening. Men who place a high value in avoiding complications from biopsies and …

National prostate cancer screening rates after the 2012 US Preventive Services Task Force recommendation discouraging prostate-specific antigen–based screening

MW Drazer, D Huo, SE Eggener - Journal of Clinical Oncology, 2015 - ascopubs.org
Purpose In 2012, the US Preventive Services Task Force (USPSTF) discouraged prostate-
specific antigen (PSA)–based prostate cancer screening. Previous USPSTF …

Structured population-based prostate-specific antigen screening for prostate cancer: the European Association of Urology position in 2019

G Gandaglia, P Albers, PA Abrahamsson, A Briganti… - European urology, 2019 - Elsevier
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe.
Screening in asymptomatic men (aged 55–69 yr) using prostate-specific antigen (PSA) is …

Recent changes in prostate cancer screening practices and epidemiology

DJ Lee, K Mallin, AJ Graves, SS Chang, DF Penson… - The Journal of …, 2017 - Elsevier
Purpose Prostate specific antigen based screening for prostate cancer has had a significant
impact on the epidemiology of the disease. Its use has been associated with a significant …

Older adults' views and communication preferences about cancer screening cessation

NL Schoenborn, K Lee, CE Pollack… - JAMA internal …, 2017 - jamanetwork.com
Importance Older adults with limited life expectancy are frequently screened for cancer even
though it exposes them to risks of screening with minimal benefit. Patient preferences may …

[HTML][HTML] Men's perspectives of prostate cancer screening: A systematic review of qualitative studies

LJ James, G Wong, JC Craig, CS Hanson, A Ju… - PloS one, 2017 - journals.plos.org
Background Prostate cancer is the most commonly diagnosed non-skin cancer in men.
Screening for prostate cancer is widely accepted; however concerns regarding the harms …

Cancer screening in the elderly: a review of breast, colorectal, lung, and prostate cancer screening

AA Kotwal, MA Schonberg - The Cancer Journal, 2017 - journals.lww.com
There are relatively limited data on outcomes of screening older adults for cancer; therefore,
the decision to screen older adults requires balancing the potential harms of screening and …